Expert Review of Vaccines, Volume 14, Issue 7 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Vaccines, Volume 14, Issue 7 (2015)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Volume 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Editorial

Editorial
Are we entering a new age for human vaccine adjuvants?
Derek T O’Hagan & Christopher B Fox
Pages: 909-911
Published online: 06 May 2015
AbstractforAre we entering a new age for human vaccine adjuvants? | Full Text | References | PDF (315.2 KB)
  • 2412 Views
  • 22 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Enveloped virus-like particle platforms: vaccines of the future?
Fabien Pitoiset, Thomas Vazquez & Bertrand Bellier
Pages: 913-915
Published online: 12 May 2015
AbstractforEnveloped virus-like particle platforms: vaccines of the future? | Full Text | References | PDF (407.5 KB)
  • 3507 Views
  • 29 CrossRef citations
  • 0Altmetric
Free Access

Review

Strategies for decision-making on vaccine use: the French experience
Pierre Loulergue, Daniel Floret & Odile Launay
Pages: 917-922
Published online: 25 Apr 2015
AbstractforStrategies for decision-making on vaccine use: the French experience | Full Text | References | PDF (287.3 KB)
  • 345 Views
  • 6 CrossRef citations
  • 0Altmetric
The impact of epidemics of vaccine-preventable disease on vaccine uptake: lessons from the 2011–2012 US pertussis epidemic
Elizabeth R Wolf, Ali Rowhani-Rahbar & Douglas J Opel
Pages: 923-933
Published online: 15 Apr 2015
AbstractforThe impact of epidemics of vaccine-preventable disease on vaccine uptake: lessons from the 2011–2012 US pertussis epidemic | Full Text | References | PDF (493.8 KB)
  • 369 Views
  • 7 CrossRef citations
  • 0Altmetric
Adversomics: a new paradigm for vaccine safety and design
Jennifer A Whitaker, Inna G Ovsyannikova & Gregory A Poland
Pages: 935-947
Published online: 02 May 2015
AbstractforAdversomics: a new paradigm for vaccine safety and design | Full Text | References | PDF (347.1 KB)
  • 455 Views
  • 42 CrossRef citations
  • 0Altmetric
Middle East respiratory syndrome: obstacles and prospects for vaccine development
Amy B Papaneri, Reed F Johnson, Jiro Wada, Laura Bollinger, Peter B Jahrling & Jens H Kuhn
Pages: 949-962
Published online: 11 Apr 2015
AbstractforMiddle East respiratory syndrome: obstacles and prospects for vaccine development | Full Text | References | PDF (704.8 KB)
  • 3507 Views
  • 23 CrossRef citations
  • 0Altmetric
Free Access
Live attenuated influenza vaccine tetravalent: a clinical review
Allyn R Bandell & Eric Simões
Pages: 963-973
Published online: 11 Apr 2015
AbstractforLive attenuated influenza vaccine tetravalent: a clinical review | Full Text | References | PDF (615 KB)
  • 584 Views
  • 7 CrossRef citations
  • 0Altmetric
PCVs in individuals at increased risk of pneumococcal disease: a literature review
Mark A Fletcher, Paul Balmer, Eric Bonnet & Nathalie Dartois
Pages: 975-1030
Published online: 17 Jun 2015
AbstractforPCVs in individuals at increased risk of pneumococcal disease: a literature review | Full Text | References | PDF (737 KB)
  • 1865 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access
The potential of plants for the production and delivery of human papillomavirus vaccines
Sergio Rosales-Mendoza & Dania O Govea-Alonso
Pages: 1031-1041
Published online: 16 Apr 2015
AbstractforThe potential of plants for the production and delivery of human papillomavirus vaccines | Full Text | References | PDF (303.2 KB)
  • 180 Views
  • 3 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine for routine pediatric vaccination programs in Japan
Masayoshi Shinjoh et al.
Article | Published online: 29 Apr 2024
Open Access
Accelerate vaccine development using seamless phase 2/3 trial designs
Jia-Ying Yang et al.
Article | Published online: 29 Apr 2024
Open Access
The zebrafish as a potential model for vaccine and adjuvant development
Peter J. Hotez et al.
Report | Published online: 25 Apr 2024
Open Access
Changing epidemiology of COVID-19: potential future impact on vaccines and vaccination strategies
Timo Ulrichs et al.
Comment | Published online: 24 Apr 2024
Open Access
View all latest articles